Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FTC’s Last Stand On Pay-For-Delay Deals? Supreme Court To Make Call On Legality

Executive Summary

The high court will determine whether brand-generic reverse payments to settle patent disputes are presumptively anticompetitive and unlawful when it takes up FTC v. Actavis; a ruling affirming the lower court would enable companies to enter agreements without the threat of litigation.


Related Content

Compromise On “Pay For Delay”? Supreme Court Hunts for Middle Ground
Supreme Court May Leave Brand-Generic Settlements Open To Further Litigation
Brand-Generic Settlements Face Tough Questions At Supreme Court As “Rule Of Reason” Analysis Finds Support
Apotex Plavix Saga May Finally Be Over; Judge Asks “What Is Going On In This Case?”
Reverse Payment Settlements Suffer Reversal Of Fortune At Third Circuit
FTC's Reverse Settlement Campaign May Depend On Congress After Another Court Loss
FTC Sues Solvay, Watson, Parr, Paddock for Settlements to Delay Generic AndroGel


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts